Chemoradiotherapy or Induction Chemotherapy Followed by Chemoradiotherapy. University Hospital Fuenlabrada: Our Experience in 10 years.

B Losada Vila

Authors

B Losada Vila

Keywords:

chemoradiotherapy, induction chemotherapy, head and neck, survival, locally advanced

Abstract

Abstract not found

Downloads

How to Cite

Chemoradiotherapy or Induction Chemotherapy Followed by Chemoradiotherapy. University Hospital Fuenlabrada: Our Experience in 10 years. (2017). Global Journal of Medical Research, 17(F1), 25-29. https://medicalresearchjournal.org/index.php/GJMR/article/view/1267

Download Citation

References

Jean-Pierre Pignon, Aurélie Maître, Emilie Maillard, Jean Bourhis (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. 92(1), 4-14.

Marshall Posner, Diane Hershock, Cesar Blajman, Elizabeth Mickiewicz, Eric Winquist, Vera Gorbounova, Sergei Tjulandin, Dong Shin, Kevin Cullen, Thomas Ervin, Barbara Murphy, Luis Raez, Roger Cohen, Monica Spaulding, Roy Tishler, Berta Roth, Rosana Viroglio, Varagur Venkatesan, Ilya Romanov, Sanjiv Agarwala, K Harter, Matthew Dugan, Anthony Cmelak, Arnold Markoe, Paul Read, Lynn Steinbrenner, A Colevas, Charles Norris, Robert Haddad (2007) Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. 357(17), 1705-1715.

Jan Vermorken, Eva Remenar, Carla Van Herpen, Thierry Gorlia, Ricard Mesia, Marian Degardin, John Stewart, Svetislav Jelic, Jan Betka, Joachim Preiss, Danielle Van Den Weyngaert, Ahmad Awada, Didier Cupissol, Heinz Kienzer, Augustin Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefebvre (2007) Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. 357(17), 1695-1704.

P Blanchard, J Bourhis, B Lacas (2013) Taxanecisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: An individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. 31, 2854-2860.

Jie Ma, Ying Liu, Xiao-Lu Huang, Zhi-Yuan Zhang, Jeffrey Myers, David Neskey, Lai-Ping Zhong (2012) Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis. 48(11), 1076-1084.

R Hitt, J Grau, A Lopez-Pousa (2009) Final results of a randomiezed phase III trial comparing induction chemotherapy with cisplatin/ 5FU or docetaxel/ cisplatin / 5FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line traeatment of unresectable locally advanced head and neck cancer (LAHNC). 27.

Robert Haddad, Guilherme Rabinowits, Roy Tishler, Douglas Adkins, Fadlo Khuri, Joseph Clark, Jochen Lorch, Sewanti Limaye, Lori Wirth, Anne O'neill, Sarah Riley, Marshall Posner (2012) The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC).. 30(15_suppl), 5501-5501.

Ezra Cohen, Theodore Karrison, Masha Kocherginsky, Chao Huang, Mark Agulnik, Bharat Mittal, Furhan Yunus, Sandeep Samant, Bruce Brockstein, Luis Raez, Ranee Mehra, Priya Kumar, Frank Ondrey, Tanguy Seiwert, Victoria Villaflor, Daniel Haraf, Everett Vokes (2012) DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).. 30(15_suppl), 5500-5500.

Maria Ghi, Adriano Paccagnella, Daris Ferrari, Paolo Foa, Maria Cossu Rocca, Elena Verri, Evaristo Maiello, Giuseppe Azzarello, Consuelo D'ambrosio, Claudia Casanova, Monica Guaraldi, Giovanni Mantovani, Ciro Rossetto, Andrea Bonetti, Tiziana Cipani, Lucio Crino, Haralabos Koussis, Gabriella Pieri, Alessandro Gava, Irene Floriani (2013) A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).. 31(15_suppl), 6003-6003.

J Bonner, P Harari (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximabinduced rash and survival. 11(1), 21-28.

Fausto Petrelli, Andrea Coinu, Valentina Riboldi, Karen Borgonovo, Mara Ghilardi, Mary Cabiddu, Veronica Lonati, Enrico Sarti, Sandro Barni (2014) Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: A systematic review and meta-analysis of published studies. 50(11), 1041-1048.